Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vericel CorpVCEL · Entity 4481 | Chief Human Resources Officer | July 22, 2025 | December 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vericel Corp
Report date July 22, 2025 · Filed December 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,854 |
Ending reported balance
After 2025-07-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-07-22 · Exercise / conversion · Acquired 2,625 · Balance 2,625 F1: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on July 22, 2024. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively. Row 2 · 2025-07-22 · Tax withholding · Disposed 771 · Balance 1,854 F2: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 7,875 |
Reported balance
After 2025-07-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-07-22 · Exercise / conversion · Acquired 2,625 · Balance 7,875 F3: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F5: The Fair Market Value of the vested derivative securities is $37.98 per share. F1: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on July 22, 2024. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively. F4: No expiration date for this type of award. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on July 22, 2024. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively.
F2: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
F3: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F4: No expiration date for this type of award.
F5: The Fair Market Value of the vested derivative securities is $37.98 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2025 Filed Dec 12, 2025 21:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 2,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-045382 · form4.xml · derivative · entry 3 Mahoney Karen · CIK 0002055280 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,875 Underlying: Common Stock · 2,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · price: The Fair Market Value of the vested derivative securities is $37.98 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on July 22, 2024. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| July 22, 2025 Filed Dec 12, 2025 21:05 UTC | Vericel Corp VCEL · Entity 4481 | Tax withholdingCommon Stock | 771 | $37.98 | $29,282.58 |
DisclosureSEC source: 0001140361-25-045382 · form4.xml · nonDerivative · entry 2 Mahoney Karen · CIK 0002055280 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,854 F2 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. Read SEC document |
| July 22, 2025 Filed Dec 12, 2025 21:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-045382 · form4.xml · nonDerivative · entry 1 Mahoney Karen · CIK 0002055280 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on July 22, 2024. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 5,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-017112 · form4.xml · derivative · entry 1 Mahoney Karen · CIK 0002055280 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,175 Underlying: Common Stock · 5,175 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 20, 2026. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 12,938 | $0.00 Strike: $54.31 | $0.00 |
DisclosureSEC source: 0001140361-25-005661 · form4.xml · derivative · entry 1 Mahoney Karen · CIK 0002055280 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,938 Underlying: Common Stock · 12,938 shares Expires 2035-02-20 F1 · derivative.exercise_date: These options shall begin vesting on February 20, 2025 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.